Litcius/Paper detail

Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use

Marina Hodolič, Wenyu Wu, Zhenyu Zhao, Fei Yu, Irene Virgolini, Feng Wang

2020European Journal of Nuclear Medicine and Molecular Imaging16 citationsDOI

Topics & Concepts

NeurotensinTolerabilityMedicineNeurotensin receptorReceptorHeart rateNuclear medicinePancreatic ductal adenocarcinomaInternal medicineBlood pressureAdverse effectPancreatic cancerCancerNeuropeptidePeptidase Inhibition and AnalysisNeuroendocrine Tumor Research AdvancesNeuropeptides and Animal Physiology
Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use | Litcius